These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11295841)

  • 1. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
    Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Matias-Guiu X; Lagarda E; Calaf M; Azpiroz A; De Leiva A; Prat J; Baiget M
    Hum Mutat; 1997; 9(5):476. PubMed ID: 9143934
    [No Abstract]   [Full Text] [Related]  

  • 3. Does phaster mean better?
    Angrist M
    Clin Chem; 1997 Mar; 43(3):424-6. PubMed ID: 9068584
    [No Abstract]   [Full Text] [Related]  

  • 4. Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.
    Bugalho MJ; Coelho I; Sobrinho LG
    Eur J Endocrinol; 2000 Jun; 142(6):573-5. PubMed ID: 10822219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.
    Kasprzak L; Nolet S; Gaboury L; Pavia C; Villabona C; Rivera-Fillat F; Oriola J; Foulkes WD
    J Med Genet; 2001 Nov; 38(11):784-7. PubMed ID: 11732489
    [No Abstract]   [Full Text] [Related]  

  • 6. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
    Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
    [No Abstract]   [Full Text] [Related]  

  • 7. A new germline mutation, R600Q, within the coding region of RET proto-oncogene: a rare polymorphism or a MEN 2 causing mutation?
    Sáez ME; Ruiz A; Cebrián A; Morales F; Robledo M; Antiñolo G; Borrego S
    Hum Mutat; 2000 Jan; 15(1):122. PubMed ID: 10612852
    [No Abstract]   [Full Text] [Related]  

  • 8. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.
    Fattoruso O; Quadro L; Libroia A; Verga U; Lupoli G; Cascone E; Colantuoni V
    Hum Mutat; 1998; Suppl 1():S167-71. PubMed ID: 9452077
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.
    Antiñolo G; Marcos I; Fernández RM; Romero M; Borrego S
    Am J Med Genet; 2002 Jun; 110(1):85-7. PubMed ID: 12116277
    [No Abstract]   [Full Text] [Related]  

  • 10. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
    Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
    Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new identified germline mutation of the RET proto-oncogene responsible for familial medullary thyroid carcinoma in co-existence with a hyperfunctioning autonomous nodule.
    Maschek W; Pichler R; Rieger R; Weinhäusel A; Berg J
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):823. PubMed ID: 12072055
    [No Abstract]   [Full Text] [Related]  

  • 12. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
    Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
    J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma.
    Alemi M; Lucas SD; Sällström JF; Bergholm U; Akerström G; Wilander E
    Oncogene; 1997 May; 14(17):2041-5. PubMed ID: 9160884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine surgery. Series 6: Alteration of RET proto-oncogene and clinical implication in medullary thyroid carcinoma. Genetic screening of family members at risk for inherited medullary thyroid carcinoma].
    Kitamura Y; Shimizu K; Tanaka S
    Nihon Ika Daigaku Zasshi; 1996 Jun; 63(3):228-32. PubMed ID: 8707923
    [No Abstract]   [Full Text] [Related]  

  • 16. The genetic background of medullary thyroid carcinoma in young patients.
    Wiench M; Wygoda Z; Gubała E; Włoch J; Oczko M; Jarzab B
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():163-4. PubMed ID: 11820587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel mutations in the RET proto-oncogene.
    Kalinin VN; Amosenko FA; Shabanov MA; Lubchenko LN; Hosch SB; Garkavtseva RF; Izbicki JR
    J Mol Med (Berl); 2001 Oct; 79(10):609-12. PubMed ID: 11692159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.
    Uchino S; Noguchi S; Yamashita H; Sato M; Adachi M; Yamashita H; Watanabe S; Ohshima A; Mitsuyama S; Iwashita T; Takahashi M
    Jpn J Cancer Res; 1999 Nov; 90(11):1231-7. PubMed ID: 10622534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
    Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.